Company Summary
Domicell’s Stem Cell Implantable Bioreactor (SCIB) is a novel cell delivery platform designed to overcome the limitations of current stem cell therapy for the heart. While conceived to prevent heart failure, SCIB-based cell therapy can be readily adapted to deliver a variety of cell products to treat other conditions, both cardiac and non-cardiac.